Skip to main content

Skin ages when the main cells in the dermis lose their identity and function

Images

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

A study in mice done at IRB Barcelona and CNAG-CRG explains that dermal fibroblasts lose their cell identify over time and with it their capacity to produce and secrete collagen and other proteins.

With age, our tissues lose their function and capacity to regenerate after being damaged. A study published today in Cell by scientists at the Institute for Research in Biomedicine (IRB Barcelona) and the Centro Nacional de Análisis Genómico of the Center for Genomic Regulation (CNAG-CRG) explains how dermal fibroblasts age.

The main conclusion drawn is that these fibroblasts lose their cell identity, as if they had “forgotten” what they are, and consequently their activity is altered, thus affecting tissue. The study reveals the cellular and molecular pathways affected by ageing and proposes that they could be manipulated to delay or even reverse the skin ageing process.

The skin

Dermal fibroblasts are key for the production of collagen and other proteins that make up the dermis and that preserve the skin’s function as a barrier. The activity of these cells is also crucial for the repair of skin damage. As we age, the dermis loses its capacity to produce collagen, and consequently its capacity to repair wounds is also significantly impaired.

“The elderly face many problems in this regard because their skin does not heal properly and its barrier properties are decreased, thus increasing the risk of skin infections and systemic infections,” explains Salvador Aznar Benitah, ICREA researcher at IRB Barcelona and leader of the study. “The notion that the loss of cell identity is one of the underlying causes of ageing is interesting and one that we believe hasn’t been considered before,” he concludes.

Holger Heyn, team leader at the CNAG-CRG and co-leader of the study, explains that “cutting-edge technologies allow molecular analysis of individual cells. In this study, we have applied advanced techniques to obtain high resolution images of fibroblasts as they age”.

First-authored by IRB Barcelona PhD student Marion Salzer, the study demonstrates that, during ageing, skin fibroblasts start to acquire many traits that are characteristic of adipocytes (fat cells). “This leads to them losing their cell identify and they also stop producing and secreting collagen like they should,” explains Salzer.
The single-cell analysis confirmed the loss of fibroblast identity in aged animals. Using sophisticated computational tools, the scientists observed that aged fibroblasts show a less defined molecular conformation compared to young fibroblasts and that “they resemble the undefined cell states observed in newborn animals,” says Heyn.

Although being basic research, Aznar Benitah comments that “this new knowledge might not only have cosmetic applications, for example anti-aging skin treatment, but more importantly, also therapeutic applications aiming to help aged skin to form scar tissue faster and more efficiently after being damaged or after an operation”.

The study has been funded by the European Research Council (ERC), the Ministry of Science through ERDFs, the Instituto de Salud Carlos III, the European Union through a Marie Curie- Skłodowska grant and Boheringer Ingelheim, through an international PhD grant awarded to Maria Salzer. The laboratory of Salvador Aznar Benitah also receives funds from the Botín Foundation and Worldwide Cancer Research, among other entities, to carry out the various research projects.

 

Reference article:

Marion Salzer, Atefeh Lafzi, Antoni Berenguer-Llergo, Catrin Youssif, Andrés Castellanos, Guiomar Solanas, Francisca Oliveira Peixoto, Camille Stephan-Otto Attolini, Neus Prats, Mònica Aguilera, Juan Martín-Caballero, Holger Heyn, and Salvador Aznar Benitah

Identity Noise and Adipogenic Traits Characterize Dermal Fibroblast Aging

Cell (2018): doi: 10.1016/j.cell.2018.10.012

 

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).